Head & Neck
IRB #H-26649: Feasibility and Outcome of CyberKnife Stereotactic Radiosurgical Boost and Salvage Therapy for Head and Neck Cancer
Advanced:
CIRB #H-29284/RTOG #R0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab For Locally-Advanced Resected Head and Neck Cancer
Symptom Management:
IRB #Pend/NCCTG#N11C5: A Phase III, Randomized, Double-Blind Study of Lactobacillus brevis CD2 Lozenges versus Placebo in the Prevention of Acute Oral Mucositis (OM) in Patients with Head and Neck Cancer Receiving Concurrent Radiotherapy and Chemotherapy (NCCTG not yet activated; not yet submitted to the IRB)
Other:
IRB #H-26283: Phase III, Randomized, Controlled, Mulit-Center Clinical Trial Evaluating the Efficacy of Electrical Stimulation for Dysphagia in Head and Neck Cancer Patients (contact Gintas @ 4-1756)
